Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2007 1
2008 3
2009 3
2010 3
2011 2
2012 2
2013 1
2014 2
2015 1
2016 2
2020 1
2021 2
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

23 results

Results by year

Filters applied: . Clear all
Page 1
The Experience of Oncology Healthcare Providers in the Central Italy during the COVID-19 Lockdown.
Fabi A, Pugliese P, Falbo PT, Corsi D, Fabbri MA, Vincenzi B, Bria E, Angelini F, Bonucci A, Pellegrino A, Falcicchio C, Caruso A, Giacomelli L, Mirisola V, Papa S, Cognetti F, Ciliberto G, Perrone M. Fabi A, et al. Among authors: mirisola v. Cancers (Basel). 2020 Oct 18;12(10):3031. doi: 10.3390/cancers12103031. Cancers (Basel). 2020. PMID: 33081044 Free PMC article.
Gene expression profile in TNF receptor-associated periodic syndrome reveals constitutively enhanced pathways and new players in the underlying inflammation.
Borghini S, Ferrera D, Prigione I, Fiore M, Ferraris C, Mirisola V, Amaro AA, Gueli I, Zammataro L, Gattorno M, Pfeffer U, Ceccherini I. Borghini S, et al. Among authors: mirisola v. Clin Exp Rheumatol. 2016 Sep-Oct;34(6 Suppl 102):S121-S128. Epub 2016 Jun 16. Clin Exp Rheumatol. 2016. PMID: 27310036
A highly invasive subpopulation of MDA-MB-231 breast cancer cells shows accelerated growth, differential chemoresistance, features of apocrine tumors and reduced tumorigenicity in vivo.
Amaro A, Angelini G, Mirisola V, Esposito AI, Reverberi D, Matis S, Maffei M, Giaretti W, Viale M, Gangemi R, Emionite L, Astigiano S, Cilli M, Bachmeier BE, Killian PH, Albini A, Pfeffer U. Amaro A, et al. Among authors: mirisola v. Oncotarget. 2016 Oct 18;7(42):68803-68820. doi: 10.18632/oncotarget.11931. Oncotarget. 2016. PMID: 27626697 Free PMC article.
Omalizumab management beyond clinical trials: the added value of a network model.
Caminati M, Senna G, Chieco Bianchi F, Marchi MR, Vianello A, Micheletto C, Pomari C, Tognella S, Savoia F, Mirisola V, Rossi A; NEONET Study Group. Caminati M, et al. Among authors: mirisola v. Pulm Pharmacol Ther. 2014 Oct;29(1):74-9. doi: 10.1016/j.pupt.2014.01.007. Epub 2014 Feb 6. Pulm Pharmacol Ther. 2014. PMID: 24508951
miR181b is induced by the chemopreventive polyphenol curcumin and inhibits breast cancer metastasis via down-regulation of the inflammatory cytokines CXCL1 and -2.
Kronski E, Fiori ME, Barbieri O, Astigiano S, Mirisola V, Killian PH, Bruno A, Pagani A, Rovera F, Pfeffer U, Sommerhoff CP, Noonan DM, Nerlich AG, Fontana L, Bachmeier BE. Kronski E, et al. Among authors: mirisola v. Mol Oncol. 2014 May;8(3):581-95. doi: 10.1016/j.molonc.2014.01.005. Epub 2014 Jan 16. Mol Oncol. 2014. PMID: 24484937 Free PMC article.
Evidence of epidermal growth factor receptor expression in uveal melanoma: inhibition of epidermal growth factor-mediated signalling by Gefitinib and Cetuximab triggered antibody-dependent cellular cytotoxicity.
Amaro A, Mirisola V, Angelini G, Musso A, Tosetti F, Esposito AI, Perri P, Lanza F, Nasciuti F, Mosci C, Puzone R, Salvi S, Truini M, Poggi A, Pfeffer U. Amaro A, et al. Among authors: mirisola v. Eur J Cancer. 2013 Oct;49(15):3353-65. doi: 10.1016/j.ejca.2013.06.011. Epub 2013 Jul 9. Eur J Cancer. 2013. PMID: 23849826
23 results